YY1 is involved in homologous recombination inhibition at guanine quadruplex sites in human cells
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Xinyu Cui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shang…. Hauptthemen laut MEDLINE: YY1 Transcription Factor, G-Quadruplexes, Homologous Recombination, Rad51 Recombinase. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Jiao Tong University.
Abstract (Originalsprache)
Homologous recombination (HR) is a key process for repairing DNA double strand breaks and for promoting genetic diversity. However, HR occurs unevenly across the genome, and certain genomic features can influence its activity. One such feature is the presence of guanine quadruplexes (G4s), stable secondary structures widely distributed throughout the genome. These G4s play essential roles in gene transcription and genome stability regulation. Especially, elevated G4 levels in cells deficient in the Bloom syndrome helicase (BLM) significantly enhance HR at G4 sites, potentially threatening genome stability. Here, we investigated the role of G4-binding protein Yin Yang-1 (YY1) in modulating HR at G4 sites in human cells. Our results show that YY1’s binding to G4 structures suppresses sister chromatid exchange after BLM knockdown, and YY1’s chromatin occupancy negatively correlates with the overall HR rate observed across the genome. By limiting RAD51 homolog 1 (RAD51) access, YY1 preferentially binds to essential genomic regions, shielding them from excessive HR. Our findings unveil a novel role of YY1–G4 interaction, revealing novel insights into cellular mechanisms involved in HR regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai 200240, China.
- National Key Laboratory of Innovative Immunotherapy, Shanghai Jiao Tong University, Shanghai 200240, China.
ORCID-Profile: Lin Li
Förderung
- Shanghai Jiao Tong University
Zitieren
APA
Cui, X., Zhang, C., Fu, C., Hu, J., Li, T., & Li, L. (2024). YY1 is involved in homologous recombination inhibition at guanine quadruplex sites in human cells. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae502
Vancouver
Cui X, Zhang C, Fu C, Hu J, Li T, Li L. YY1 is involved in homologous recombination inhibition at guanine quadruplex sites in human cells. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae502
BibTeX
@article{Cui2024,
author = {Cui, Xinyu and Zhang, Chengwen and Fu, Chunqing and Hu, Jinglei and Li, Tengjiao and Li, Lin},
title = {YY1 is involved in homologous recombination inhibition at guanine quadruplex sites in human cells},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae502}
}
EUVIMED